Chongqing Pharma debuts with $150m
Chongqing Pharmaceutical (Group) Co is making its debut in the loan market for $150m. It is set to directly compete against a larger Chinese state-owned peer that is also testing lenders’ appetite for a new fundraising.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: